CSL, an Australian biotech firm, announced a reduced profit forecast and postponed its vaccine division spin-off, attributing the decision to a historic drop in U.S. flu vaccination rates. This development has sent the company's shares plummeting by as much as 16.6%, marking a nearly seven-year low. At CSL's annual meeting in Melbourne, shareholders expressed dissatisfaction with the company's declining share price and rejected executive pay packages for a second consecutive year; however, the board remained intact after overcoming a spill motion.

In a separate development, U.S. Health Secretary Robert F. Kennedy Jr. has instructed the Centers for Disease Control and Prevention to investigate potential health risks associated with offshore wind farms. Bloomberg News reported that this ini

See Full Page